產(chǎn)品詳情
簡(jiǎn)單介紹：
人角質(zhì)形成細(xì)胞生長(zhǎng)因子-2 / FGF-10重組蛋白與其它公司提供的重組蛋白不同，-2 / FGF-10重組蛋白產(chǎn)品為采用CFS的無細(xì)胞麥胚蛋白合成系統(tǒng)表達(dá)出來的重組蛋白，可表達(dá)出對(duì)細(xì)胞有毒性、易被蛋白酶降解的蛋白；并獲得具有良好的可溶性，并有翻譯后修飾、從而部分具有功能的蛋白.同時(shí)獨(dú)有的全自動(dòng)蛋白純化技術(shù)則簡(jiǎn)便高效，將蛋白純化過程中對(duì)蛋白的損傷降低到*小程度.人角質(zhì)形成細(xì)胞生長(zhǎng)因子-2 / FGF-10重組蛋白（全長(zhǎng)序列）產(chǎn)品可用于Western Blot驗(yàn)證、抗體制備、蛋白檢測(cè)、ELISA等試驗(yàn)中.
詳情介紹：
人角質(zhì)形成細(xì)胞生長(zhǎng)因子-2 / FGF-10重組蛋白
| Species | Human |
| Accession | O15520 |
| GeneID | 2255 |
| Source | Escherichia coli. |
| Molecular Weight | Approximately 19.1 kDa, a single, non-glycosylated polypeptide chain containing 169 amino acids. |
| Quantity | 5μg/25μg/1000μg |
| AA Sequence | LGQDMVSPEA TNSSSSSFSS PSSAGRHVRS YNHLQGDVRW RKLFSFTKYF LKIEKNGKVS GTKKENCPYS ILEITSVEIG VVAVKAINSN YYLAMNKKGK LYGSKEFNND CKLKERIEEN GYNTYASFNW QHNGRQMYVA LNGKGAPRRG QKTRRKNTSA HFLPMVVHS |
| Purity | 人角質(zhì)形成細(xì)胞生長(zhǎng)因子-2 / FGF-10重組蛋白> 97 % by SDS-PAGE and HPLC analyses. |
| Biological Activity | Fully biologically active when compared to standard. The ED50 as determined by thymidine uptake assay using FGF-receptors transfected BaF3 cells is less than 0.5 ng/ml, corresponding to a specific activity of > 2.0 × 106 IU/mg. |
| Physical Appearance | Sterile Filtered White lyophilized (freeze-dried) powder. |
| Formulation | 人角質(zhì)形成細(xì)胞生長(zhǎng)因子-2 / FGF-10重組蛋白Lyophilized from a 0.2 μm filtered concentrated solution in 2 × PBS, pH 7.4. |
| Endotoxin | Less than 1 EU/μg of rHuKGF-2/FGF-10 as determined by LAL method. |
| Reconstitution | We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions. |
| Storage | This lyophilized preparation is stable at 2-8 °C, but should be kept at -20 °C for long term storage, preferably desiccated. Upon reconstitution, the preparation is stable for up to one week at 2-8 °C. For maximal stability, apportion the reconstituted preparation into working aliquots and store at -20 °C to -70 °C. Avoid repeated freeze/thaw cycles. |
|
|
人角質(zhì)形成細(xì)胞生長(zhǎng)因子-2 / FGF-10重組蛋白 |
| SDS-PAGE |
|
| Reference |
1. Emoto H, Tagashira S, Mattei MG, et al. 1997. J Biol Chem. 272:23191-4. 2. Tagashira S, Harada H, Katsumata T, et al. 1997. Gene. 197:399-404. 3. Carninci P, Kasukawa T, Katayama S, et al. 2005. Science. 309:1559-63. 4. Igarashi M, Finch PW, Aaronson SA. 1998. J Biol Chem. 273:13230-5. 5. Entesarian M, Matsson H, Klar J, et al. 2005. Nat Genet. 37:125-7. |
| Background | 人角質(zhì)形成細(xì)胞生長(zhǎng)因子-2 / FGF-10重組蛋白Fibroblast growth factor 10 belongs to the fibroblast growth factor (FGF) family which is involved in a variety of biological processes such as embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. Like most other FGF family members, FGF-10 also has a heparin-binding domain and it plays an important role in the regulation of embryonic development, cell proliferation and cell differentiation. In addition, FGF-10 may play a role in wound healing and is required for normal branching morphogenesis. Recombinant human FGF-10 contains a 208 amino acids and it shares 92 % and 95 % amino acid sequence identity with murine and rat FGF-10. Defects in FGF-10 are the cause of autosomal dominant aplasia of lacrimal and salivary glands and lacrimo-auriculo-dento-digital syndrome. |
